Related Experiment Video

Updated: Apr 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.2K

ELECTIVE PERCUTANEOUS CORONARY INTERVENTIONS--A COMPARISION OF EFFICACY OF CLOPIDOGREL AND PRASUGREL

Shahzeb, Nasir Ali, Abdul Hadi

    Journal of Ayub Medical College, Abbottabad : JAMC
    |July 18, 2015
    PubMed

    Insights

    Prasugrel demonstrates superior efficacy in inhibiting platelet aggregation compared to clopidogrel. This finding is crucial for patients undergoing percutaneous coronary interventions, highlighting prasugrel

    Area of Science:

    • Cardiology
    • Pharmacology
    • Interventional Cardiology

    Background:

    • Percutaneous coronary interventions (PCIs) commonly utilize antiplatelet drugs like clopidogrel and prasugrel to prevent stent thrombosis.
    • These medications are essential for reducing mortality and morbidity post-PCI.
    • Comparing the efficacy of these agents is vital for optimizing patient outcomes.

    Purpose of the Study:

    • To compare the antiplatelet efficacy of clopidogrel versus prasugrel in patients undergoing elective PCI.
    • To evaluate the degree of platelet aggregation inhibition by both drugs.

    Main Methods:

    • A randomized controlled trial involving 148 patients undergoing elective PCI.
    • Patients were allocated to receive either clopidogrel (Group A, n=74) or prasugrel (Group B, n=74).
    • Platelet aggregation was measured at baseline and 6 hours post-drug administration.

    Main Results:

    • Prasugrel group showed significantly greater inhibition of platelet aggregation (3.47 ± 1.8 ohm) compared to the clopidogrel group (5.88 ± 2.9 ohm) at 6 hours (p=0.001).
    • A higher percentage of patients in the prasugrel group achieved >10% platelet aggregation inhibition (97.3%) versus the clopidogrel group (85.15%) (p=0.009).
    • Demographic and baseline characteristics were similar between the groups.

    Conclusions:

    • Prasugrel is more efficacious than clopidogrel in inhibiting platelet aggregation.
    • This enhanced inhibition may translate to improved outcomes in patients undergoing PCI.
    • Prasugrel represents a more effective option for antiplatelet therapy in this patient population.
    Abstract

    More Related Videos

    Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

    Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

    Published on: December 16, 2022

    4.7K
    Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

    Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

    Published on: May 26, 2023

    2.8K

    Related Concept Videos

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    1.5K
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    587
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    613
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    419
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    473
    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

    Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

    Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
    672